Effective August 2, 2022, mdxhealth has acquired the Oncotype DX Genomic Prostate Score (GPS) test from Exact Sciences. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the press release.
Questions? Email: gps@mdxhealth.com

Closing the Gap in Colon Cancer Management

The Oncotype DX Colon Recurrence Score® test takes you beyond traditional measurements to predict each patient’s individualized risk of recurrence.

Every patient is different. That means every tumor is different. With the genomic-based insights of the Oncotype DX® tests, you can make informed decisions with data catered to each patients’ unique scenario.

Order a test

You can order tests through the physician portal. You must first request a specimen kit to submit a sample by calling +1 866-ONCOTYPE (+1 866-662-6897) before completing a requisition form on the portal. Once you order, we then work with the pathology team or treating physician to obtain the sample using the specimen kit.